Cytokinetics Inc vs Veritone Inc — how do they compare? Cytokinetics Inc trades at $76.27 (market cap $10.63B), while Veritone Inc trades at $1.46 (market cap $138.04M). The key difference: Cytokinetics Inc is far larger — about 77× Veritone Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | VERI | |
|---|---|---|
Market Cap | $10.63B | $138.04M |
Sector | Technology | Technology |
52-Week High | $87.26 | $8.39 |
52-Week Low | $34.31 | $1.00 |
Enterprise Value | $10.74B | $170.07M |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →